PFA
BNTX icon

Paradigm Financial Advisors’s BioNTech BNTX Stock Holding History

Paradigm Financial Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$5.52M Sell
21,398
-1,072
-5% -$294K 1.22% 24
2021
Q3 		$6.13M Sell
22,470
-740
-3% -$235K 1.41% 23
2021
Q2 		$5.2M Sell
23,210
-640
-3% -$121K 1.16% 27
2021
Q1 		$2.6M Sell
23,850
-831
-3% -$88.3K 0.63% 45
2020
Q4 		$2.01M Buy
+24,681
New +$2.42M 0.54% 45

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Paradigm Financial Advisors's BNTX Position: Q4 2021 in Review

Paradigm Financial Advisors reduced its BioNTech (BNTX) stake by 4.8% in Q4 2021, selling an estimated $294K and leaving 21,398 shares worth $5.52M. The position accounts for 1.22% of the portfolio, ranked #24.

Paradigm Financial Advisors first reported a position in BNTX in Q4 2020 and has held it in 5 quarters since. The position peaked at $6.13M in Q3 2021. 354 funds tracked by Wall St. Rank hold BNTX as of Q4 2021.

  • Paradigm Financial Advisors held 21,398 shares of BioNTech worth $5.52M as of Q4 2021.
  • Paradigm Financial Advisors sold 1,072 BioNTech shares in Q4 2021, an estimated $294K.
  • BioNTech made up 1.22% of Paradigm Financial Advisors's portfolio in Q4 2021, its #24 holding.
  • Paradigm Financial Advisors first reported a position in BioNTech in Q4 2020 and has held it in 5 quarters since.
  • Paradigm Financial Advisors's BioNTech position peaked at $6.13M in Q3 2021.
  • 354 funds tracked by Wall St. Rank held BioNTech as of Q4 2021.

Based on Paradigm Financial Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.